U.S. Markets closed

Synergy Pharmaceuticals Inc. (SGYP)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
2.91+0.01 (+0.34%)
At close: 4:00PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development89,56278,02883,274
Selling General and Administrative55,72421,79411,004
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-145,286-99,822-94,278
Income from Continuing Operations
Total Other Income/Expenses Net-39,931-3941,445
Earnings Before Interest and Taxes-198,607-117,500-95,708
Interest Expense---
Income Before Tax-198,607-117,500-95,708
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-198,607-117,500-95,708
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-198,607-117,500-95,708
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-198,607-117,500-95,708